Search For

Yu U Xie, 5728 Algonquian Dr, Natick, MA 01760

Yu Xie Phones & Addresses

28 Algonquian Dr, Natick, MA 01760    508-5451402   

Newton Center, MA   

Cambridge, MA   

Wellesley, MA   

Mentions for Yu U Xie

Professional Records

Medicine Doctors

Yu Xie Photo 1

Yu Xie

Business Records

Name / TitleCompany / ClassificationPhones & Addresses
Yu Yi Xie LUCKY YEE, LLC

Publications

Us Patents

Vinyl-Phenyl Derivatives For Inflammation And Immune-Related Uses

US Patent:
7816535, Oct 19, 2010
Filed:
Jan 25, 2007
Appl. No.:
11/699002
Inventors:
Gary Bohnert - Cambridge MA,
Shoujun Chen - Bedford MA,
Yu Xie - Natick MA,
Assignee:
Synta Pharmaceuticals Corp. - Lexington MA
International Classification:
C07D 213/44
US Classification:
546262, 546329, 546340, 514277
Abstract:
The invention relates to compounds of structural formula (Ia):.

Method For Modulating Calcium Ion-Release-Activated Calcium Ion Channels

US Patent:
2005014, Jul 7, 2005
Filed:
Jul 22, 2004
Appl. No.:
10/897682
Inventors:
Yu Xie - Natick MA,
Mats Holmqvist - Malden MA,
Jerome Mahiou - Lexington MA,
Mitsunori Ono - Lexington MA,
Lijun Sun - Harvard MA,
Shoujun Chen - Bedford MA,
Shijie Zhang - Nashua NH,
Jun Jiang - Acton MA,
Dinesh Chimmanamada - Waltham MA,
Andrea Fleig - Honolulu HI,
Chih-Yi Yu - Malden MA,
International Classification:
A61K031/724
A61K031/444
A61K031/4439
A61K031/4196
A61K031/381
A61K031/35
US Classification:
514332000, 514340000, 514422000, 514058000, 514383000, 514397000, 514451000, 514438000
Abstract:
The invention relates to a method for modulating Ca-release-activated Ca channels (CRAC) in a cell by administering to the cell a compound of formula (I): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof wherein X, Y, A, Z, L and n are defined herein.

Thiazole And Thiadiazole Compounds For Inflammation And Immune-Related Uses

US Patent:
2013031, Nov 28, 2013
Filed:
May 16, 2013
Appl. No.:
13/895590
Inventors:
Shoujun Chen - Bedford MA,
Qinglin Che - Foxboro MA,
Yu Xie - Natick MA,
Assignee:
Synta Pharmaceuticals Corp. - Lexington MA
International Classification:
C07D 277/46
A61K 45/06
C07D 417/12
A61K 31/4439
A61K 31/433
C07D 285/135
C07D 417/10
A61K 31/427
C07D 417/14
A61K 31/444
A61K 31/5377
A61K 31/426
C07D 417/04
US Classification:
5142368, 548195, 514371, 5462687, 514342, 548127, 514361, 546256, 514333, 544131, 548139, 514363
Abstract:
The invention relates to compounds of structural formula (I):

Compounds For Inflammation And Immune-Related Uses

US Patent:
2013030, Nov 21, 2013
Filed:
Jul 23, 2013
Appl. No.:
13/948541
Inventors:
Shoujun Chen - Bedford MA,
Jun Jiang - Norwood MA,
Yu Xie - Natick MA,
Chih-Yi Yu - Malden MA,
Assignee:
Synta Pharmaceuticals Corp. - Lexington MA
International Classification:
C07D 241/20
C07D 405/14
C07D 417/14
C07D 413/10
C07D 403/10
C07D 413/14
C07D 401/12
C07D 401/14
US Classification:
4242781, 435375
Abstract:
The invention relates to compounds of structural formula (I) and structural formula (VI):or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein R, R, R, Z, L, and n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.

Vinyl-Phenyl Derivatives For Inflammation And Immune-Related Uses

US Patent:
2011001, Jan 20, 2011
Filed:
Sep 28, 2010
Appl. No.:
12/892448
Inventors:
Gary Bohnert - Cambridge MA,
Shoujun Chen - Bedford MA,
Yu Xie - Natick MA,
Assignee:
Synta Pharmaceuticals Corp. - Lexington MA
International Classification:
A61K 31/55
A61K 31/44
A61K 31/444
A61K 31/167
A61K 31/421
A61K 31/505
A61K 31/426
A61K 31/24
A61K 31/4439
A61K 31/506
A61K 31/497
A61P 29/00
A61P 37/06
A61P 19/02
A61P 19/08
A61P 1/00
A61P 11/06
A61P 11/00
A61P 27/02
A61P 17/06
A61P 17/00
A61P 25/28
A61P 25/00
A61P 25/16
A61P 37/02
A61P 35/00
A61P 9/10
A61P 9/00
A61P 15/00
A61P 1/16
A61P 3/00
A61P 31/00
US Classification:
51421711, 514355, 514332, 514354, 514357, 514617, 514374, 514256, 514365, 514539, 514342, 514333, 514334, 514275, 51425505
Abstract:
The invention relates to compounds of structural formula (Ia):or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein X, X, X, X, X, X, R, Y, Z, L, and n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.

Pyridylphenyl Compounds For Inflammation And Immune-Related Uses

US Patent:
2010024, Sep 30, 2010
Filed:
Mar 29, 2010
Appl. No.:
12/749317
Inventors:
Jun Jiang - Norwood MA,
Zhi-Qiang Xia - Acton MA,
Junyi Zhang - Lowell MA,
Gary Bohnert - Cambridge MA,
Shoujun Chen - Bedford MA,
Yu Xie - Natick MA,
Assignee:
Synta Pharmaceuticals Corp - Lexington MA
International Classification:
A61K 31/4439
A61K 31/4418
A61P 29/00
A61P 37/00
C12N 5/071
C12N 5/0781
C12N 5/0783
US Classification:
514342, 514352, 514340, 435325, 435326
Abstract:
The invention relates to compounds of structural formula (I):or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein Y, L, X, X, Z, R, R, and n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.

Pyridylphenyl Compounds For Inflammation And Immune-Related Uses

US Patent:
2007025, Nov 1, 2007
Filed:
Jan 31, 2007
Appl. No.:
11/701170
Inventors:
Jun Jiang - Norwood MA,
Zhi-Qiang Xia - Acton MA,
Junyi Zhang - Lowell MA,
Gary Bohnert - Cambridge MA,
Shoujun Chen - Bedford MA,
Yu Xie - Natick MA,
International Classification:
A61K 31/44
C07D 211/70
C07D 211/72
C07D 213/72
US Classification:
514345000, 514352000, 514357000, 546301000, 546304000, 546329000, 546339000
Abstract:
The invention relates to compounds of structural formula (I): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein Y, L, X, X, Z, R, R, and n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.

Compounds For Inflammation And Immune-Related Uses

US Patent:
2007024, Oct 25, 2007
Filed:
Sep 21, 2005
Appl. No.:
11/233224
Inventors:
Shoujun Chen - Bedford MA,
Jun Jiang - Acton MA,
Hao Li - Brookline MA,
David James - Cambridge MA,
Dinesh Chimmanamada - Waltham MA,
Christopher Borella - Cambridge MA,
Lijun Sun - Harvard MA,
Yu Xie - Natick MA,
Mats Holmqvist - Malden MA,
Jerome Mahiou - Lexington MA,
Zhi Xia - Acton MA,
Assignee:
Synta Pharmaceuticals Corp. - Lexington MA
International Classification:
A61K 31/44
A61K 31/40
A61K 31/415
A61P 19/02
A61P 5/00
C07D 235/28
C07D 471/02
C07D 455/02
C07D 235/00
A61P 3/10
A61P 17/00
A61K 31/437
US Classification:
514303000, 514299000, 514393000, 514394000, 514395000, 546118000, 546121000, 548304400, 548307100
Abstract:
The invention relates to compounds of formula (I): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof wherein X, Y, A, Z, L and n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions and immune disorders.

Isbn (Books And Publications)

Marriage And Cohabitation

Author:
Yu Xie
ISBN #:
0226798666

Statistical Methods For Categorical Data Analysis

Author:
Yu Xie
ISBN #:
0125637365

Women In Science: Career Processes And Outcomes

Author:
Yu Xie
ISBN #:
0674010345

Women In Science: Career Processes And Outcomes

Author:
Yu Xie
ISBN #:
0674018591

All data offered is derived from public sources. We do not verify or evaluate each piece of data, and makes no warranties or guarantees about any of the information offered. We do not possess or have access to secure or private financial information. Background Check is not a credit reporting agency and does not offer consumer reports. None of the information offered by Background Check is to be considered for purposes of determining any entity or person's eligibility for credit, insurance, employment, housing, or for any other purposes covered under the FCRA.